Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
The international coalition of medicines regulatory authorities (ICMRA)
2015 Skerritt, J.; De Oliveira, J. C. M.; Arora, A.; Rasi, G.; Rys, A.; O'Mahony, P.; Pani, L.; Kondo, T.; Hurts, H.; Ling, M. C. M.; Hela, M.; Hudson, I.; Hamburg, M.
Ecology, distribution and expansion of a Mediterranean native invader, the fireworm Hermodice carunculata (Annelida)
2020 Righi, S.; Prevedelli, D.; Simonini, R.
Less tautology, more biology? A comment on “high-density” morphometrics
2020 Cardini, A.
Licensing of generic medicines: Are there any challenges left? A pharmaceutical regulatory perspective
2014 Borg, J. J.; Tomasi, P.; Pani, L.; Aislaitner, G.; Pirozynski, M.; Leufkens, H.; Melchiorri, D.
Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden - Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials
2011 Isaac, M.; Vamvakas, S.; Abadie, E.; Jonsson, B.; Gispen, C.; Pani, L.
Biosimilars: The paradox of sharing the same pharmacological action without full chemical identity
2013 Pani, L.; Montilla, S.; Pimpinella, G.; Bertini Malgarini, R.
Unexplained somatic symptoms during major depression: Prevalence and clinical impact in a national sample of italian psychiatric outpatients
2011 Perugi, G.; Canonico, P. L.; Carbonato, P.; Mencacci, C.; Muscettola, G.; Pani, L.; Torta, R.; Vampini, C.; Fornaro, M.; Parazzini, F.; Dumitriu, A.
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice
2010 Luongo, L.; Palazzo, E.; Tambaro, S.; Giordano, C.; Gatta, L.; Scafuro, M. A.; Rossi, F. S.; Lazzari, P.; Pani, L.; De Novellis, V.; Malcangio, M.; Maione, S.
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats
2010 Marchese, G.; Pittau, B.; Casu, G.; Peddio, G.; Spada, G. P.; Pira, M.; Deriu, A.; Portesani, F.; Pisu, C.; Lazzari, P.; Pani, L.
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry
2014 Montilla, S.; Marchesini, G.; Sammarco, A.; Trotta, M. P.; Siviero, P. D.; Tomino, C.; Melchiorri, D.; Pani, L.; Melchiorri, D.; Sbraccia, P.; Nicolucci, A.; Brignoli, O.; Coscelli, C.; Dell'Aera, M.; Mazzaglia, G.; Giustini, S. E.; De Rosa, M.; Covezzoli, A.; Rigazio, A.; Roncadori, A.
High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA)
2014 Onder, G.; Bonassi, S.; Abbatecola, A. M.; Folino-Gallo, P.; Lapi, F.; Marchionni, N.; Pani, L.; Pecorelli, S.; Sancarlo, D.; Scuteri, A.; Trifiro, G.; Vitale, C.; Zuccaro, S. M.; Bernabei, R.; Fini, M.
Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union
2015 Ehmann, F.; Papaluca, M.; Di Giuseppe, F.; Pani, L.; Eskova, A.; Manolis, E.; Herold, R.
Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells
2010 Sanna, D.; Sanna, A.; Mara, L.; Pilichi, S.; Mastinu, A.; Chessa, F.; Pani, L.; Dattena, M.
Reflections on decisions made on the well-established use of medicinal products by EU regulators and the ECJ
2014 Borg, J. J.; Laslop, A.; Pani, L.; Maciulaitis, R.; Melchiorri, D.
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review
2013 Renda, F.; Mura, P.; Finco, G.; Ferrazin, F.; Pani, L.; Landoni, G.
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis
2015 Savarese, G.; Perrone-Filardi, P.; D'Amore, C.; Vitale, C.; Trimarco, B.; Pani, L.; Rosano, G. M. C.
Five mutations in the GABAA α6 gene 5′ flanking region are associated with a reduced basal and ethanol-induced α6 upregulation in mutated Sardinian alcohol non-preferring rats
2005 Saba, L.; Porcella, A.; Sanna, A.; Congeddu, E.; Marziliano, N.; Mongeau, R.; Grayson, D.; Pani, L.
Use and reimbursement of off-label drugs in pediatric anesthesia: The Italian experience
2014 Salvo, I.; Landoni, G.; Mucchetti, M.; Cabrini, L.; Pani, L.
Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions
2010 Lazzari, P.; Fadda, P.; Marchese, G.; Casu, G. L.; Pani, L.
The future is now: Model-based clinical trial design for Alzheimer's disease
2015 Romero, K.; Ito, K.; Rogers, J. A.; Polhamus, D.; Qiu, R.; Stephenson, D.; Mohs, R.; Lalonde, R.; Sinha, V.; Wang, Y.; Brown, D.; Isaac, M.; Vamvakas, S.; Hemmings, R.; Pani, L.; Bain, L. J.; Corrigan, B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The international coalition of medicines regulatory authorities (ICMRA) | 1-gen-2015 | Skerritt, J.; De Oliveira, J. C. M.; Arora, A.; Rasi, G.; Rys, A.; O'Mahony, P.; Pani, L.; Kondo, T.; Hurts, H.; Ling, M. C. M.; Hela, M.; Hudson, I.; Hamburg, M. | |
| Ecology, distribution and expansion of a Mediterranean native invader, the fireworm Hermodice carunculata (Annelida) | 1-gen-2020 | Righi, S.; Prevedelli, D.; Simonini, R. | |
| Less tautology, more biology? A comment on “high-density” morphometrics | 1-gen-2020 | Cardini, A. | |
| Licensing of generic medicines: Are there any challenges left? A pharmaceutical regulatory perspective | 1-gen-2014 | Borg, J. J.; Tomasi, P.; Pani, L.; Aislaitner, G.; Pirozynski, M.; Leufkens, H.; Melchiorri, D. | |
| Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden - Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials | 1-gen-2011 | Isaac, M.; Vamvakas, S.; Abadie, E.; Jonsson, B.; Gispen, C.; Pani, L. | |
| Biosimilars: The paradox of sharing the same pharmacological action without full chemical identity | 1-gen-2013 | Pani, L.; Montilla, S.; Pimpinella, G.; Bertini Malgarini, R. | |
| Unexplained somatic symptoms during major depression: Prevalence and clinical impact in a national sample of italian psychiatric outpatients | 1-gen-2011 | Perugi, G.; Canonico, P. L.; Carbonato, P.; Mencacci, C.; Muscettola, G.; Pani, L.; Torta, R.; Vampini, C.; Fornaro, M.; Parazzini, F.; Dumitriu, A. | |
| 1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice | 1-gen-2010 | Luongo, L.; Palazzo, E.; Tambaro, S.; Giordano, C.; Gatta, L.; Scafuro, M. A.; Rossi, F. S.; Lazzari, P.; Pani, L.; De Novellis, V.; Malcangio, M.; Maione, S. | |
| A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats | 1-gen-2010 | Marchese, G.; Pittau, B.; Casu, G.; Peddio, G.; Spada, G. P.; Pira, M.; Deriu, A.; Portesani, F.; Pisu, C.; Lazzari, P.; Pani, L. | |
| Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry | 1-gen-2014 | Montilla, S.; Marchesini, G.; Sammarco, A.; Trotta, M. P.; Siviero, P. D.; Tomino, C.; Melchiorri, D.; Pani, L.; Melchiorri, D.; Sbraccia, P.; Nicolucci, A.; Brignoli, O.; Coscelli, C.; Dell'Aera, M.; Mazzaglia, G.; Giustini, S. E.; De Rosa, M.; Covezzoli, A.; Rigazio, A.; Roncadori, A. | |
| High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) | 1-gen-2014 | Onder, G.; Bonassi, S.; Abbatecola, A. M.; Folino-Gallo, P.; Lapi, F.; Marchionni, N.; Pani, L.; Pecorelli, S.; Sancarlo, D.; Scuteri, A.; Trifiro, G.; Vitale, C.; Zuccaro, S. M.; Bernabei, R.; Fini, M. | |
| Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union | 1-gen-2015 | Ehmann, F.; Papaluca, M.; Di Giuseppe, F.; Pani, L.; Eskova, A.; Manolis, E.; Herold, R. | |
| Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells | 1-gen-2010 | Sanna, D.; Sanna, A.; Mara, L.; Pilichi, S.; Mastinu, A.; Chessa, F.; Pani, L.; Dattena, M. | |
| Reflections on decisions made on the well-established use of medicinal products by EU regulators and the ECJ | 1-gen-2014 | Borg, J. J.; Laslop, A.; Pani, L.; Maciulaitis, R.; Melchiorri, D. | |
| Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review | 1-gen-2013 | Renda, F.; Mura, P.; Finco, G.; Ferrazin, F.; Pani, L.; Landoni, G. | |
| Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis | 1-gen-2015 | Savarese, G.; Perrone-Filardi, P.; D'Amore, C.; Vitale, C.; Trimarco, B.; Pani, L.; Rosano, G. M. C. | |
| Five mutations in the GABAA α6 gene 5′ flanking region are associated with a reduced basal and ethanol-induced α6 upregulation in mutated Sardinian alcohol non-preferring rats | 1-gen-2005 | Saba, L.; Porcella, A.; Sanna, A.; Congeddu, E.; Marziliano, N.; Mongeau, R.; Grayson, D.; Pani, L. | |
| Use and reimbursement of off-label drugs in pediatric anesthesia: The Italian experience | 1-gen-2014 | Salvo, I.; Landoni, G.; Mucchetti, M.; Cabrini, L.; Pani, L. | |
| Antinociceptive activity of Δ9-tetrahydrocannabinol non-ionic microemulsions | 1-gen-2010 | Lazzari, P.; Fadda, P.; Marchese, G.; Casu, G. L.; Pani, L. | |
| The future is now: Model-based clinical trial design for Alzheimer's disease | 1-gen-2015 | Romero, K.; Ito, K.; Rogers, J. A.; Polhamus, D.; Qiu, R.; Stephenson, D.; Mohs, R.; Lalonde, R.; Sinha, V.; Wang, Y.; Brown, D.; Isaac, M.; Vamvakas, S.; Hemmings, R.; Pani, L.; Bain, L. J.; Corrigan, B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69889
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720224
- 2010 - 201923518
- 2000 - 200914314
- 1990 - 19998032
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2681
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy768
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58344
- ita10791
- fre334
- spa300
- ger189
- por61
- rus24
- und23
- chi15
- pol7
Accesso al fulltext
- no fulltext29937
- open19792
- reserved18705
- partially open1441
- embargoed15
- mixed1
